drugset
drugset / Trial / NCT00368160

Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy Volunteers

NCT00368160 ↗

Phase 1 Completed 32 enrolled Sumitomo Pharma America, Inc.
RandomizedCrossoverTriple-blindTreatment

Summary

Male and female healthy volunteers. Patients must also possess a full current driving license (for at least one year), and be a regular car driver.

Timeline

Start
2004-03
Primary completion
2005-07
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Eszopiclone Small molecule 3 mg —

Indications

insomnia